Help stop deceptive prescription drug marketing

Deceptive prescription drug marketing is widespread and dangerous. One of the worst forms of deceptive marketing is the suppression or misrepresentation of clinical trial data. Bills A2591/S2307 solve this problem by forcing the disclosure of accurate and complete clinical trial information.

By passing A2951/S2307, New Jersey can stop the marketers from undermining the science of pharmaceutical medicine.

The first step in making these bills law is passing them through committee. Ask Asm. Conaway, Chairman of the Health and Senior Services committee and sponsor of A2951, to have the bill considered at the next committee meeting.

Follow these 3 easy steps to help out.
1. Look over the message below, and feel free to add your own comments. Using your own words makes the message more meaningful.
2. Sign the letter by filling in the form below. We will not share your information with anyone else.
3. Click the button to send your message.